Compared to healthy volunteers, we observed a reduced proportion of CD14++ CD16− in blood from RA patients and a significant increase of both CD14+ CD16+ and CD14low CD16++ monocytes (Fig. 1a–b). This evidence concerns the gene CD14 and rheumatoid arthritis.